Petlife Pharmaceuticals Stock Price, News & Analysis
Company Description
Petlife Pharmaceuticals (OTC Link: PTLF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $393.5K.
PTLF stock has gained 0.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of PTLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Petlife Pharmaceuticals (PTLF) stock last traded at $0.0001. At a market capitalization of $393.5K, PTLF is classified as a micro-cap stock with approximately 196.8M shares outstanding.
Latest News
Petlife Pharmaceuticals has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all PTLF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PTLF Company Profile & Sector Positioning
Petlife Pharmaceuticals (PTLF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PTLF often look at related companies in the same sector, including Greater Cannabis (GCAN), CuraScientific copr (CSTF), Livewire (LVVV), Levitee Labs (LVTTF), and Digicann Ventures Inc. (AGFAF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PTLF's relative position within its industry.